• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Issue Issue 2
Issue Issue 1
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Helmy, T., Al Awady, S., El Syaad, M., Mokhtar, A., Elfeky, M. (2025). EFFICACY OF ACETAZOLAMIDE IN MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE WITH VOLUME OVERLOAD. ALEXMED ePosters, 7(2), 52-53. doi: 10.21608/alexpo.2025.389601.2179
Tamer Helmy; Samir Al Awady; Mohamed Saad El Syaad; Ahmed Mokhtar; Mohamed Sobhy Abd-ElGawad Elfeky. "EFFICACY OF ACETAZOLAMIDE IN MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE WITH VOLUME OVERLOAD". ALEXMED ePosters, 7, 2, 2025, 52-53. doi: 10.21608/alexpo.2025.389601.2179
Helmy, T., Al Awady, S., El Syaad, M., Mokhtar, A., Elfeky, M. (2025). 'EFFICACY OF ACETAZOLAMIDE IN MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE WITH VOLUME OVERLOAD', ALEXMED ePosters, 7(2), pp. 52-53. doi: 10.21608/alexpo.2025.389601.2179
Helmy, T., Al Awady, S., El Syaad, M., Mokhtar, A., Elfeky, M. EFFICACY OF ACETAZOLAMIDE IN MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE WITH VOLUME OVERLOAD. ALEXMED ePosters, 2025; 7(2): 52-53. doi: 10.21608/alexpo.2025.389601.2179

EFFICACY OF ACETAZOLAMIDE IN MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE WITH VOLUME OVERLOAD

Article 1, Volume 7, Issue 2, April 2025, Page 52-53  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2025.389601.2179
View on SCiNiTO View on SCiNiTO
Authors
Tamer Helmy1; Samir Al Awady2; Mohamed Saad El Syaad3; Ahmed Mokhtar4; Mohamed Sobhy Abd-ElGawad Elfeky email 5
1Critical Care Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
2Critical Care Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
3Department of Critical Care Medicine
4faculty of medicine, alexandria university, cardiology and angiology department
5Department of Critical Care Medicine, Alexandria University
Abstract
Heart failure (HF) is a major global health concern, affecting 1–3% of the adult population and leading to frequent hospital admissions. Acute decompensated heart failure (ADHF) is a life-threatening condition marked by rapid worsening of chronic HF symptoms, commonly associated with volume overload. Despite advancements in therapy, ADHF remains a major clinical challenge. Traditional treatment includes loop diuretics to relieve fluid overload. However, diuretic resistance and adverse effects on renal function limit their efficacy. Acetazolamide, a carbonic anhydrase inhibitor with diuretic properties, has emerged as a potential adjunct therapy to improve decongestion without worsening kidney function. This study investigates the impact of adding acetazolamide to standard loop diuretic therapy in managing volume overload among patients with ADHF and reduced ejection fraction.

AIM OF THE WORK:
The aim of this study was to assess whether the addition of acetazolamide to loop diuretics improves decongestion in patients with acute decompensated heart failure with volume overload.
Keywords
Heart failure (HF); Acetazolamide; Decongestion
Supplementary Files
download 2179 0 - 2025-05-25T100808.386.pdf
Statistics
Article View: 39
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.